JAMA Network Open is shining a spotlight on impactful research on opioids in the primary care setting conducted by Bellin Health and Bellin Pharmacy Clinical Coordinator Andy Cohen, in conjunction with the University of Wisconsin-Madison Implementation Science & Engineering Lab.
Their article “Strategies to Deimplement Opioid Prescribing in Primary Care” is being released today in the journal’s latest edition.
The article details a trial that evolved from a change framework strategy that was widely shared in the news media, leading to two five-year National Institutes of Health (NIH) grants totaling nearly $5 million to implement interventions for preventing and treating substance misuse in primary care.
Those grant funds were used to design what is now referred to as the Balanced Opioid Initiative, which was published at the onset of COVID-19.
Cohen says the direct work Bellin Health did to address opioid prescribing can be used as a framework for others, and that he expects “our work to continue to help guide not only our region but others across the country as we overcome this challenge together.”
